Importance of thrombosis and thrombolysis in silent ischaemia: comparison of patients with acute myocardial infarction and unstable angina

Br Heart J. 1994 Feb;71(2):151-5. doi: 10.1136/hrt.71.2.151.

Abstract

Objective: To investigate whether plaque rupture and thrombosis have a role in silent ischaemia as well as in unstable angina.

Design: Prospective analysis of the results of haemostatic diagnostic tests at the moment of developing silent ischaemia at rest.

Setting: Coronary care unit.

Patients: 22 patients with acute myocardial infarction, 12 patients with symptomatic angina (unstable angina), and 10 normal volunteers (control group).

Interventions: Continuous cardiac monitoring detected 15 asymptomatic episodes (silent ischaemia) in 6 patients with unstable angina. Blood samples were obtained at admission and when an asymptomatic alteration was detected and 10 minutes later.

Main outcome measures: Comparisons of concentrations of tissue plasminogen activator, urokinase type plasminogen activator, tissue plasminogen activator inhibitor-1, cross-linked fibrin degradation products, von Willebrand factor, and thrombin-antithrombin III complexes in patients and controls at admission; same comparisons in patients with silent ischaemia at the start of an episode and 10 minutes later.

Results: Tissue plasminogen activator concentrations were raised at admission in patients with acute myocardial infarction (mean (SD) 14.2 (6) ng/ml) and in patients with unstable angina (10.1 (2.5) ng/ml) in comparison with controls (5.1 (2.7) ng/ml, p < 0.01 and < 0.05 respectively). There was no differences between the two groups of patients, however. Similar results were observed at the start of a silent ischaemic episode (9.8 (1.9) ng/ml) and 10 minutes later (10.5 (2.9) ng/ml) compared with controls (p < 0.05). Tissue plasminogen activator inhibitor-1 concentrations were raised in patients with acute myocardial infarction (45.1 (15) ng/ml) compared with volunteers (20.6 (16) ng/ml, p < 0.01). In patients with silent ischaemia tissue plasminogen activator inhibitor-1 concentrations were slightly but not significantly increased. Concentrations of cross-linked fibrin degradation products (D dimer) increased during unstable angina (2150 (350) ng/ml) and silent ischaemia (2270 (450) ng/ml) compared with the concentrations in volunteers (340 (80) ng/ml) and patients with acute myocardial infarction (310 (120) ng/ml; p < 0.01).

Conclusions: The results suggest that thrombosis mediates the pathophysiological mechanisms of silent ischaemia and unstable angina.

Publication types

  • Comparative Study

MeSH terms

  • Angina, Unstable / blood
  • Angina, Unstable / etiology*
  • Electrocardiography, Ambulatory
  • Female
  • Fibrinolysis / physiology
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / blood
  • Myocardial Infarction / etiology*
  • Myocardial Ischemia / blood
  • Myocardial Ischemia / diagnosis
  • Myocardial Ischemia / etiology*
  • Plasminogen Activator Inhibitor 1 / blood
  • Prospective Studies
  • Thrombosis / blood
  • Thrombosis / complications*
  • Tissue Plasminogen Activator / blood

Substances

  • Plasminogen Activator Inhibitor 1
  • Tissue Plasminogen Activator